& Radua, J
Instead, these FDA-approved medications work primarily by reducing appetite, slowing gastric emptying, and decreasing caloric intake
After 72 weeks of treatment, nearly two-thirds of participants who received Wegovy showed resolution of liver inflammation (steatohepatitis) without any worsening of fibrosis, almost twice the rate seen in the placebo group
How much risk remains hotly debated
(Not to mention the price tag.) Ive checked in a couple of times since then, most recently in the autumn, but this update feels different because this time, I walked out of my doctors office with the best news Ive gotten in years
Since then, several RCTs and meta-analyses have shown beneficial histological improvements after the administration of PIO in individuals with overweight/obesity, prediabetes and T2D who experience NASH